**Targeting TRAIL Receptors with Genetically-Engineered CD34+ Hematopoietic Stem Cells**

Carmelo Carlo-Stella, Arianna Giacomini, Silvia L. Locatelli, Cristiana Lavazza and Alessandro M. Gianni *Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori and University of Milano Italy* 
